Gal‐1 promotes lung cancer cell survival by enhancing PARP1 / H1 .2 interaction to promote DNA repair upon DNA damage response
The FEBS Journal · 2025
DOI: 10.1111/febs.70134 ↗Kurz gefasst
Fachartikel in der Zeitschrift The FEBS Journal, 2025. Verfasst von Yihao Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of life Sciences, Wuhan University, Wuhan, China. Hauptthemen laut MEDLINE: Poly (ADP-Ribose) Polymerase-1, Lung Neoplasms, DNA Repair, Galectin 1. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: Hubei Province's Special Fund for Guiding Local Scientific and Technological Development by the Central Government.
Abstract (Originalsprache)
Galectin‐1 ( Gal‐1 ), a member of the galectin family, has emerged as a regulator of tumor progression. Several studies have reported the upregulation of Gal‐1 expression in multiple cancer cells and its promotion on tumor proliferation. However, the mechanism by which Gal‐1 promotes tumor growth remains to be thoroughly understood. In this study, it was discovered that high expression of Gal‐1 in various cancers was inversely correlated with the overall survival of patients. Through constructing Gal‐1 ‐overexpressing cell lines, it was uncovered that cell proliferation and colony formation were significantly improved. The results of transcriptomic and proximity‐labeling‐based proteomic analyses indicated that Gal‐1 interacted with poly [ADP‐ribose] polymerase 1 (PARP1) and histone H1.2 in lung cancer cells. In the case of etoposide treatment leading to DNA double‐strand break, Gal‐1 accelerated the degradation of H1.2 by enhancing its interaction with PARP1 and promoting its PARylation. It caused the activation of downstream DNA repair pathways such as the serine‐protein kinase ATM and nibrin (NBS1) signaling pathways, thus reducing apoptosis, and the Gal‐1 inhibitor thiodigalactoside (TDG) could restore cell sensitivity to etoposide. Upon knockdown of Gal‐1 , DNA damage led to impaired activation of ATM and NBS1 phosphorylation, thereby increasing the sensitivity of the A549 cell line to etoposide. Finally, using a tumor‐bearing mouse model, we observed that, in tumors with high Gal‐1 expression, the combination treatment of TDG and etoposide significantly inhibited tumor growth. This study provides new clues for the role of Gal‐1 in the development of tumors and renders suggestions for the medication of patients with high Gal‐1 expression in the clinic.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of life Sciences, Wuhan University, Wuhan, China.
- Hubei Key Laboratory of Cell Homeostasis, Wuhan University, Wuhan, China.
ORCID-Profile: Yihao Chen, Hui Sun
Förderung
- Hubei Province's Special Fund for Guiding Local Scientific and Technological Development by the Central Government
Zitieren
APA
Chen, Y., Liu, X., Li, B., Xie, X., Xia, J., & Sun, H. (2025). Gal‐1 promotes lung cancer cell survival by enhancing PARP1 / H1 .2 interaction to promote DNA repair upon DNA damage response. The FEBS Journal. https://doi.org/10.1111/febs.70134
Vancouver
Chen Y, Liu X, Li B, Xie X, Xia J, Sun H. Gal‐1 promotes lung cancer cell survival by enhancing PARP1 / H1 .2 interaction to promote DNA repair upon DNA damage response. The FEBS Journal. 2025. doi:10.1111/febs.70134
BibTeX
@article{Chen2025,
author = {Chen, Yihao and Liu, Xiaomei and Li, Buju and Xie, Xinru and Xia, Jin and Sun, Hui},
title = {Gal‐1 promotes lung cancer cell survival by enhancing PARP1 / H1 .2 interaction to promote DNA repair upon DNA damage response},
journal = {The FEBS Journal},
year = {2025},
doi = {10.1111/febs.70134}
}
EUVIMED